- Biotechnology
- Thursday, 01 Apr 2021
Europe Drug Modelling Software Market Volume Analysis, Segments, Value Share and Key Trends 2020-2027
According to our new market research study on “Europe Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Type, and Application” the market is expected to reach US$ 3,215.94 million by 2027 from US$ 1,826.99 million in 2019; it is estimated to grow at a CAGR of 7.6% from 2020 to 2027. The report provides trends prevailing in the Europe drug modelling software market and the factors driving the market growth along with those hindering it.
In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.
Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013989/
Company Profiles
- Crown Bioscience Inc (JSR life science)
- Genedata AG
- Biognos AB
- Dassault Systèmes
- Acellera
The growth of the Europe drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the lack of data standardization is the major factor hindering the market growth in Europe.
Genedata AG; Biognos AB; Dassault Systèmes; Acellera; and Crown Bioscience Inc (JSR life science) are among the leading companies operating in the Europe drug modelling software market.
EUROPE DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013989/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
Artax Biopharma Announces the Formation of Scientific Advisory Board to Advance Autoimmune Disease Therapy AX-158
Jun 25, 2020
Medical Audiometer Devices Market Is Rising With Post COVID-19 Impact Analysis, Development,CAGR , Forecast To 2021-2027
Mar 25, 2021
Hansa Biopharma to Participate in Two Upcoming Investor Conferences
Feb 25, 2020
Gene Synthesis Market 2021 Global Industry Analysis, Size, Investment Analysis, Trends, Growth, Development Factors, Future Scope, Challenges and 2025 Forecast Research Report
Feb 10, 2021
Biodetectors Market – Know What Segments & Players Seeking Heavy Attention
May 03, 2021
US Blood Bank Market Trends, Business Strategies and Opportunities With Key Players Analysis 2027
Sep 09, 2020
Neurological Disorder Diagnostics Market Qualitative Analysis Reveals Explosive Growth by 2027:
May 06, 2021